HRT Financial’s LeMaitre Vascular LMAT Stock Holding History

HRT Financial’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,272	Closed	-$3.63M	–	4848
2026 Q1	$3.63M	Buy	+33,272	New	+$3.17M	0.01%	1192
2025 Q1	–	Sell	-9,083	Closed	-$836K	–	2997
2024 Q4	$836K	Buy	9,083 +5,663	+166%	+$545K	﹤0.01%	1164
2024 Q3	$317K	Buy	+3,420	New	+$296K	﹤0.01%	1786
2024 Q2	–	Sell	-6,643	Closed	-$440K	–	2703
2024 Q1	$440K	Buy	+6,643	New	+$410K	﹤0.01%	1335
2023 Q2	–	Sell	-16,144	Closed	-$830K	–	2903
2023 Q1	$830K	Buy	+16,144	New	+$784K	0.01%	1047
2022 Q1	–	Sell	-4,465	Closed	-$224K	–	3511
2021 Q4	$224K	Buy	+4,465	New	+$231K	﹤0.01%	2466
2021 Q2	–	Sell	-4,275	Closed	-$208K	–	3219
2021 Q1	$208K	Buy	+4,275	New	+$200K	﹤0.01%	2292

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRT Financial's LMAT Position: Q2 2026 in Review

HRT Financial sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 33,272 shares — an estimated $3.63M sold.

HRT Financial first reported a position in LMAT in Q1 2021 and held it in 7 quarters. The position peaked at $3.63M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

HRT Financial reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 33,272 LeMaitre Vascular shares in Q2 2026, an estimated $3.63M.
HRT Financial first reported a position in LeMaitre Vascular in Q1 2021 and held it in 7 quarters.
HRT Financial's LeMaitre Vascular position peaked at $3.63M in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.